Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xu Ran

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Journal of Medicinal Chemistry|July 18, 2018
Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain InhibitorYujun Zhao, Bing Zhou, Longchuan Bai, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 19, 2024
Prognostic value of lymphocytes in patients with breast cancer receiving radiotherapy after breast-conserving surgery: A post hoc analysis of a phase III randomized trialYu-Chun Song, Si-Ye Chen, Xu-Ran Zhao, et al.
Breast (Edinburgh, Scotland)|December 23, 2021
Effect of postmastectomy radiotherapy on pT<sub>1-2</sub>N<sub>1</sub> breast cancer patients with different molecular subtypesXin-Yuan Guo, Guang-Yi Sun, Hong-Mei Wang, et al.
Frontiers in Oncology|February 12, 2021
Trastuzumab Provides a Comparable Prognosis in Patients With HER2-Positive Breast Cancer to Those With HER2-Negative Breast Cancer: <i>Post Hoc</i> Analyses of a Randomized Controlled Trial of Post-Mastectomy Hypofractionated RadiotherapyGuang-Yi Sun, Hao Jing, Shu-Lian Wang, et al.
BMC Cancer|November 7, 2021
POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trialXu-Ran Zhao, Hui Fang, Yu Tang, et al.
Technology in Cancer Research & Treatment|June 14, 2023
Voluntary Deep Inspiration Breath-Hold (VDIBH) Whole-Breast Irradiation Assisted by Optical Surface Monitoring System (OSMS) in Patients With Left-Sided Breast Cancer: A Prospective Phase II StudyJiang-Hu Zhang, Tan-Tan Li, Shi-Rui Qin, et al.
Future Cardiology|May 14, 2025
Effect of thymosin α1 on Immune response and organ function in acute aortic dissection surgery: PANDA II trial protocolHong Liu, Si-Chong Qian, Ying-Yuan Zhang, et al.
Frontiers in Oncology|March 1, 2021
Prognosis and Prophylactic Regional Nodal Irradiation in Breast Cancer Patients With the First Isolated Chest Wall Recurrence After MastectomyXu-Ran Zhao, Liang Xuan, Jun Yin, et al.
Frontiers in Oncology|October 19, 2020
Timing of Chemotherapy and Radiotherapy Following Breast-Conserving Surgery for Early-Stage Breast Cancer: A Retrospective AnalysisSi-Ye Chen, Yu Tang, Shu-Lian Wang, et al.
Frontiers in Oncology|January 6, 2023
Risk factors to identify the indication for regional nodal irradiation in T1-2N1M0 breast cancer: A joint analysis of 4,243 real-world cases from two institutionsGuang-Yi Sun, Ge Wen, Yu-Jing Zhang, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Journal of Medicinal Chemistry|July 18, 2018
Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain InhibitorYujun Zhao, Bing Zhou, Longchuan Bai, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 19, 2024
Prognostic value of lymphocytes in patients with breast cancer receiving radiotherapy after breast-conserving surgery: A post hoc analysis of a phase III randomized trialYu-Chun Song, Si-Ye Chen, Xu-Ran Zhao, et al.
Breast (Edinburgh, Scotland)|December 23, 2021
Effect of postmastectomy radiotherapy on pT<sub>1-2</sub>N<sub>1</sub> breast cancer patients with different molecular subtypesXin-Yuan Guo, Guang-Yi Sun, Hong-Mei Wang, et al.
Frontiers in Oncology|February 12, 2021
Trastuzumab Provides a Comparable Prognosis in Patients With HER2-Positive Breast Cancer to Those With HER2-Negative Breast Cancer: <i>Post Hoc</i> Analyses of a Randomized Controlled Trial of Post-Mastectomy Hypofractionated RadiotherapyGuang-Yi Sun, Hao Jing, Shu-Lian Wang, et al.
BMC Cancer|November 7, 2021
POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trialXu-Ran Zhao, Hui Fang, Yu Tang, et al.
Technology in Cancer Research & Treatment|June 14, 2023
Voluntary Deep Inspiration Breath-Hold (VDIBH) Whole-Breast Irradiation Assisted by Optical Surface Monitoring System (OSMS) in Patients With Left-Sided Breast Cancer: A Prospective Phase II StudyJiang-Hu Zhang, Tan-Tan Li, Shi-Rui Qin, et al.
Future Cardiology|May 14, 2025
Effect of thymosin α1 on Immune response and organ function in acute aortic dissection surgery: PANDA II trial protocolHong Liu, Si-Chong Qian, Ying-Yuan Zhang, et al.
Frontiers in Oncology|March 1, 2021
Prognosis and Prophylactic Regional Nodal Irradiation in Breast Cancer Patients With the First Isolated Chest Wall Recurrence After MastectomyXu-Ran Zhao, Liang Xuan, Jun Yin, et al.
Frontiers in Oncology|October 19, 2020
Timing of Chemotherapy and Radiotherapy Following Breast-Conserving Surgery for Early-Stage Breast Cancer: A Retrospective AnalysisSi-Ye Chen, Yu Tang, Shu-Lian Wang, et al.
Frontiers in Oncology|January 6, 2023
Risk factors to identify the indication for regional nodal irradiation in T1-2N1M0 breast cancer: A joint analysis of 4,243 real-world cases from two institutionsGuang-Yi Sun, Ge Wen, Yu-Jing Zhang, et al.
Pageof 14